Afuco™ Anti-Human PDCD1LG2 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-PDCD1LG2 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The anti-PD-L2 antibodies is against PD-L2 which are ligands for PD-1. It can be used to detect and isolate PD-L2 proteins, regulate the bioavailability of PD-L2 proteins, and modulate PD-L2 activity, with the use of treatment for persistent infectious diseases, autoimmune diseases, asthma, transplant rejection, inflammatory disorders and tumors.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-723CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | PDCD1LG2 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples. |